CPH.TO vs. DRX.TO
CPH.TO (Cipher Pharmaceuticals Inc.) and DRX.TO (ADF Group Inc.) are both stocks. CPH.TO operates in Drug Manufacturers - Specialty & Generic (Healthcare), while DRX.TO operates in Metal Fabrication (Industrials). Over the past 10 years, CPH.TO returned 8.89%/yr vs 13.53%/yr for DRX.TO. At a 0.04 correlation, their price movements are largely independent.
Performance
CPH.TO vs. DRX.TO - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both stocks are quite close, with CPH.TO having a 12.08% return and DRX.TO slightly lower at 11.96%. Over the past 10 years, CPH.TO has underperformed DRX.TO with an annualized return of 8.89%, while DRX.TO has yielded a comparatively higher 13.53% annualized return.
CPH.TO
- 1D
- 0.24%
- 1M
- -14.49%
- YTD
- 12.08%
- 6M
- 15.14%
- 1Y
- 27.40%
- 3Y*
- 64.67%
- 5Y*
- 61.01%
- 10Y*
- 8.89%
DRX.TO
- 1D
- -3.47%
- 1M
- -2.09%
- YTD
- 11.96%
- 6M
- 35.50%
- 1Y
- 54.30%
- 3Y*
- 43.18%
- 5Y*
- 44.18%
- 10Y*
- 13.53%
CPH.TO vs. DRX.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CPH.TO Cipher Pharmaceuticals Inc. | 12.08% | 5.17% | 158.48% | 44.27% | 116.95% | 90.32% | -38.00% | -12.28% | -65.10% | 0.00% |
DRX.TO ADF Group Inc. | 11.96% | -4.88% | 41.10% | 231.76% | 31.96% | 9.42% | 16.92% | 28.41% | -51.53% | -25.31% |
Correlation
The correlation between CPH.TO and DRX.TO is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.08 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.06 |
Correlation (All Time) Calculated using the full available price history since Jul 6, 2006 | 0.04 |
The correlation between CPH.TO and DRX.TO shifts across timeframes, from 0.04 (all time) to 0.17 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
CPH.TO:
CA$435.58M
DRX.TO:
CA$169.54M
CPH.TO:
CA$1.19
DRX.TO:
CA$1.07
CPH.TO:
14.22
DRX.TO:
9.59
CPH.TO:
0.17
DRX.TO:
0.18
CPH.TO:
8.65
DRX.TO:
0.98
CPH.TO:
3.28
DRX.TO:
0.92
CPH.TO:
CA$50.92M
DRX.TO:
CA$258.74M
CPH.TO:
CA$37.95M
DRX.TO:
CA$59.38M
CPH.TO:
CA$25.12M
DRX.TO:
CA$43.53M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CPH.TO vs. DRX.TO — Risk / Return Rank
CPH.TO
DRX.TO
CPH.TO vs. DRX.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cipher Pharmaceuticals Inc. (CPH.TO) and ADF Group Inc. (DRX.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CPH.TO | DRX.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.17 | ||
| Sortino ratioReturn per unit of downside risk | -0.57 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.23 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | 1.21 | 1.71 | -0.51 |
| Martin ratioReturn relative to average drawdown | 2.53 | 3.25 | -0.72 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CPH.TO | DRX.TO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.66 | 0.83 | -0.17 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.23 | 0.76 | +0.47 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.15 | 0.24 | -0.09 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.08 | 0.21 | -0.12 |
Drawdowns
CPH.TO vs. DRX.TO - Drawdown Comparison
The maximum CPH.TO drawdown since its inception was -97.90%, which is greater than DRX.TO's maximum drawdown of -91.59%. Use the drawdown chart below to compare losses from any high point for CPH.TO and DRX.TO.
Loading charts...
Drawdown Indicators
| CPH.TO | DRX.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.90% | -91.59% | -6.31% |
Max Drawdown (1Y)Largest decline over 1 year | -22.83% | -31.86% | +9.03% |
Max Drawdown (3Y)Largest decline over 3 years | -42.50% | -74.49% | +31.99% |
Max Drawdown (5Y)Largest decline over 5 years | -42.50% | -74.49% | +31.99% |
Max Drawdown (10Y)Largest decline over 10 years | -94.63% | -82.12% | -12.51% |
Current DrawdownCurrent decline from peak | -14.49% | -49.31% | +34.82% |
Average DrawdownAverage peak-to-trough decline | -64.03% | -61.70% | -2.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.84% | 16.75% | -5.91% |
Volatility
CPH.TO vs. DRX.TO - Volatility Comparison
Cipher Pharmaceuticals Inc. (CPH.TO) and ADF Group Inc. (DRX.TO) have volatilities of 13.91% and 13.37%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CPH.TO | DRX.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.91% | 13.37% | +0.54% |
Volatility (6M)Calculated over the trailing 6-month period | 28.45% | 40.87% | -12.42% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.97% | 66.17% | -24.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 49.95% | 58.63% | -8.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.78% | 56.73% | +4.05% |
Dividends
CPH.TO vs. DRX.TO - Dividend Comparison
CPH.TO has not paid dividends to shareholders, while DRX.TO's dividend yield for the trailing twelve months is around 0.39%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CPH.TO Cipher Pharmaceuticals Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
DRX.TO ADF Group Inc. | 0.39% | 0.43% | 0.31% | 0.29% | 0.95% | 1.24% | 1.34% | 1.54% | 1.94% | 0.93% | 0.69% | 0.68% |
Financials
CPH.TO vs. DRX.TO - Financials Comparison
This section allows you to compare key financial metrics between Cipher Pharmaceuticals Inc. and ADF Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CPH.TO vs. DRX.TO - Profitability Comparison
CPH.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cipher Pharmaceuticals Inc. reported a gross profit of 8.35M and revenue of 12.30M. Therefore, the gross margin over that period was 67.9%.
DRX.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ADF Group Inc. reported a gross profit of 16.93M and revenue of 78.79M. Therefore, the gross margin over that period was 21.5%.
CPH.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cipher Pharmaceuticals Inc. reported an operating income of 5.50M and revenue of 12.30M, resulting in an operating margin of 44.7%.
DRX.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ADF Group Inc. reported an operating income of 9.02M and revenue of 78.79M, resulting in an operating margin of 11.5%.
CPH.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cipher Pharmaceuticals Inc. reported a net income of 6.06M and revenue of 12.30M, resulting in a net margin of 49.3%.
DRX.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ADF Group Inc. reported a net income of 6.36M and revenue of 78.79M, resulting in a net margin of 8.1%.
Frequently Asked Questions
CPH.TO and DRX.TO have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for CPH.TO and DRX.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer